ICOMET - Analysis of the genetic expression contribution towards the development of metastases in colon cancer patients with no lymph node involvement

Head :
Olschwang Sylviane, CENTRE DE RECHERCHE EN CANCÉROLOGIE DE MARSEILLE UMR891 INSERM
Saurin , CELLULES ENDOCRINES ET DIGESTIVES NORMALES ET NÉOPLASIQUES U865 INSERM

Last update : 06/18/2014 | Version : 1 | ID : 60160

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Analysis of the genetic expression contribution towards the development of metastases in colon cancer patients with no lymph node involvement
Sign or acronym ICOMET
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation no. iCOMET/IPC 2009-002. Avis CCTIRS et CPP
General Aspects
Medical area Cancer research
Health determinants Genetic
Others (details) Colon cancer with no lymph node involvement
Keywords Health episodes, onset, metastases
Scientific investigator(s) (Contact)
Name of the director Olschwang
Surname Sylviane
Address 13009 MARSEILLE
Phone + 33 (0)4 91 22 34 06
Email sylviane.olschwang@inserm.fr
Unit CENTRE DE RECHERCHE EN CANCÉROLOGIE DE MARSEILLE UMR891 INSERM
Organization INSERM
Name of the director Saurin
Address 69003 LYON
Phone + 33 (0)4 78 86 16 89
Email jean-christophe.saurin@chu-lyon.fr
Unit CELLULES ENDOCRINES ET DIGESTIVES NORMALES ET NÉOPLASIQUES U865 INSERM
Organization INSERM
Collaborations
Participation in projects, networks and consortia Yes
Funding
Funding status Private
Details ASSOCIATION POUR LE RECHERCHE CONTRE LE CANCER (ARC) LABORATOIRE SERVIER INTERNATIONAL
Governance of the database
Sponsor(s) or organisation(s) responsible CLCC INSTITUT PAOLI-CALMETTES
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Prospective Inclusion cut-off date: 01/08/2013 Patients with colon cancer, 1/3 having metastases at follow-up, 2/3 living without metastases at follow-up
Database objective
Main objective General objective: to analyse genetic expression contribution towards the development of metastases Secondary objective: to analyse genetic expression contribution towards histologic and genetic types of colon cancer
Inclusion criteria Adults with sporadic colon cancer
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Population covered Sick population
Gender Male
Woman
Geography area National
Detail of the geography area Multicentric cohort throughout France (40 centres):
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 09/2009
Date of last collection (YYYY or MM/YYYY) 02/2019
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 7800
Data
Database activity Current data collection
Type of data collected Clinical data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Biological data (detail) Type of samples taken: Blood and fixed tissue
Presence of a biobank Yes
Contents of biobank Tissues
DNA
Details of biobank content DNA bank, tumour bank
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Clinical examinations: direct input Biological analysis: direct input
Participant monitoring Yes
Details on monitoring of participants Follow-up duration: 54 months
Links to administrative sources No
Promotion and access
Promotion
Access
Terms of data access (charter for data provision, format of data, availability delay) Data may be used by academic teams Access subject to favourable opinion of the scientific committee Raw clinical and biological database available Biological specimen aliquots for target characterisation available - To be decided if data may be used by industrial teams
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here